About Synaptogenix, Inc. 
Synaptogenix, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 3 Schemes (1.4%)
Foreign Institutions
Held by 9 Foreign Institutions (1.57%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Dec 2025)
Net Profit:
-8 Million
Pharmaceuticals & Biotechnology
USD 48 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.01
-40.86%
2.86






